Your browser doesn't support javascript.
loading
Dynamic borrowing from a single prior data source using the conditional power prior.
Thompson, Laura; Chu, Jianxiong; Xu, Jianjin; Li, Xuefeng; Nair, Rajesh; Tiwari, Ram.
Afiliación
  • Thompson L; Division of Biostatistics, Center for Biologics and Evaluation Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States.
  • Chu J; Division of Biostatistics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, United States.
  • Xu J; Division of Biostatistics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, United States.
  • Li X; Division of Biostatistics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, United States.
  • Nair R; Division of Biostatistics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, United States.
  • Tiwari R; Division of Biostatistics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, United States.
J Biopharm Stat ; 31(4): 403-424, 2021 07 04.
Article en En | MEDLINE | ID: mdl-34520325
The conditional power prior is a popular method to borrow information from a single prior data source. The amount of borrowing is controlled by the power parameter which is fixed before running the new study. However, fixing this parameter before running a new study is often difficult and may be unwise because if the outcomes in the current study are much different from the prior data outcomes, the power parameter cannot be changed to reflect a more appropriate degree of borrowing. On the other hand, treating the power parameter as a random variable to be updated via Bayes theorem may relinquish control over how much to borrow in cases where regulatory oversight recommends a conservative approach.Previous authors have determined the power parameter at the end of the current study based on "stochastic" similarity in the outcomes between the current study and the prior data. In this paper, we introduce some modifications to those methods. First, we determine the power parameter based on similarity between a percentage of the current study outcome data available at an interim look and the prior outcome data. This may limit potential for operational bias resulting from the determination of the power parameter after the current study is complete. Next, we introduce a new measure of similarity between the current (interim) and prior data that limits similarity by a pre-specified clinical margin. The proposed clinical similarity region may be readily understood by clinicians who need to assess when such borrowing is clinically appropriate. Through simulations, we show that our approach has low bias and good power, while reducing type I error rate in areas outside of the "similarity region". An example of a hypothetical medical device study illustrates its potential use in practice.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Almacenamiento y Recuperación de la Información Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biopharm Stat Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Almacenamiento y Recuperación de la Información Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biopharm Stat Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos